This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cleophas, T. J. M. Articles by van 't Laar, A. Search for Related Content PubMed PubMed Citation Articles by Cleophas, T. J. M. Articles by van 't Laar, A. Social Bookmarking                         What's this?

Treatment of Raynaud's Syndrome with Adrenergic Alpha-Blockade with or without Beta-Blockade

Division of General Internal Medicine, Department of Medicine, Radboud Hospital, University of Nijmegen, Nijmegen, The Netherlands

Henk J. J. van Lier

Division of General Internal Medicine, Department of Medicine, Radboud Hospital, University of Nijmegen, Nijmegen, The Netherlands

Jan F. M. Fennis

Division of General Internal Medicine, Department of Medicine, Radboud Hospital, University of Nijmegen, Nijmegen, The Netherlands

Albert van 't Laar

Division of General Internal Medicine, Department of Medicine, Radboud Hospital, University of Nijmegen, Nijmegen, The Netherlands

In a double blind placebo-controlled cross-over trial of 24 weeks 31 patients with Raynaud's syndrome were treated with the alpha-blocker phenoxybenzamine (10-20 mg daily) and with the combination of the alpha-blocker phenoxybenzamine (10-20 mg daily) and the beta-blocker sotalol (40-80 mg daily). A favourable effect on recovery of finger temperature after finger cooling was demonstrated after alpha-blockade as com pared to the before treatment situation. This favourable effect was not different when the group received the combined alpha- and beta-blockade. The blood pressure was not influenced by either of the 2 medications. Fluid retention appeared with alpha-blockade and was absent with combined alpha- and beta-blockade. Decrease of heart rate oc curred with alpha- plus beta-blockade and was absent with alpha-blockade alone. Clinical symptoms of Raynaud's syndrome equally were alleviated by the two medica tions. Common, and equally frequent side effects of the two medications were nasal congestion, disturbed ejaculation and potence, dry mouth, exercise-induced and ortho- static dizziness.

We conclude that alpha-blockade is beneficial in Raynaud's syndrome and that additional beta-blockade counteracts the alpha-blocker side-effect fluid retention, re duces the heart rate and thus may prevent alpha-blocker induced tachycardia, and that it does not cause hypotension.

Angiology, Vol. 35, No. 1, 29-37 (1984)
DOI: 10.1177/000331978403500104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T.J.M. Cleophas Interaction in Cardiovascular Crossover Studies: The Standard and the Clinical Analysis Angiology, April 1, 1993; 44(4): 271 - 277. [Abstract] [PDF]

				T. J. M. Cleophas and M. G. Niemeyer Raynaud's Syndrome, an Enigma After 130 Years Angiology, March 1, 1993; 44(3): 196 - 209. [Abstract] [PDF]

				T. J. M. Cleophas Underestimation of Treatment Effect in Crossover Trials Angiology, September 1, 1990; 41(9): 673 - 680. [Abstract] [PDF]

				T. J. Cleophas Testing Crossover Studies for Carryover Effects Angiology, April 1, 1989; 40(4): 287 - 293. [Abstract] [PDF]